CENTOGENE is a leading life science company specializing in rare and neurodegenerative diseases, providing data-driven solutions to patients, physicians, and pharmaceutical companies. With a vast biodatabank of 800,000 individuals and 400,000 collected biosamples, they work collaboratively with patients, physicians, and partners to diagnose, understand, and treat these complex diseases.
By integrating omic data and creating comprehensive atlases of rare diseases, CENTOGENE aims to diagnose patients accurately. They also focus on understanding disease pathways and faulty genes to provide valuable insights for pharmaceutical partners in developing targeted treatments. With their multiomic technologies, they identify drug targets with greater certainty, making drug development for rare diseases more financially viable. Their ultimate goal is to enable the cure of 100 diseases within a decade.
Generated from the website